Investigation Shows Planned Parenthood Putting Women at Risk With Dangerous Abortion Pills

A pro-life organization has released an undercover video investigation showing the nation’s biggest abortion company putting women at risk with dangerous abortion pills.

The new video shows that Planned Parenthood facilities nationwide are failing to implement basic safety protocols when distributing abortion pills, putting women at heightened risk of serious complications including hemorrhage, incomplete abortion, and life-threatening infection.

Live Action, a national pro-life group, published its investigative report and video titled “Abortion Pill Exposed.” The investigation involved callers contacting Planned Parenthood centers across multiple states to inquire about obtaining the abortion pill regimen (mifepristone and misoprostol) via telehealth and mail.

According to the report, Planned Parenthood staff did not require confirmation of gestational age of the baby, or require ultrasounds, medical screenings, counseling, checks for contraindications or Rh negativity, or in-person follow-up care. Without these, women can and have died from using abortion pills and they are flooding ERs with multiple medical problems from botched abortions.

HELP LIFENEWS SAVE BABIES FROM ABORTION! Please help LifeNews.com with a donation!

Facilities reportedly agreed to mail pills to alternative addresses to conceal use from parents, send them even if the woman was unsure about proceeding, and provided no routine post-administration monitoring.

The investigation highlights that by bypassing these measures, Planned Parenthood operates more as a drug dispensary than a medical provider, increasing dangers from the abortion pill.

In the video, Planned Parenthood staff referred to the unborn baby as “tissue” and downplayed the severity of bleeding and other symptoms associated with the pill. One representative claimed that taking the abortion pill is safer for the mother than “carrying to term,” which is false.

Live Action cited an Ethics & Public Policy Center analysis indicating a nearly 11% rate of serious adverse events — including sepsis, infection, and hemorrhage — within 45 days of use, described as 22 times higher than the FDA’s reported rate of less than 0.5% on the mifepristone label. The group also noted underreporting of complications, as women are often instructed to seek emergency care without disclosing the abortion pill as the cause, which distorts safety data.

Live Action founder and president Lila Rose presented the findings at a press conference on Capitol Hill ahead of the annual March for Life.

In a letter to HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, Live Action stated: “For more than two decades, mifepristone has remained on the market under an approval process that was politically accelerated, shielded from transparency, and repeatedly expanded without regard for patient safety, adverse event reporting, or statutory compliance. Since its approval in 2000, this drug has ended the lives of approximately 7.5 million children in the United States. Live Action’s investigation now publicly documents how those regulatory failures in safety manifest in clinical practice, particularly within Planned Parenthood facilities tasked with administering this drug under federal safeguards.

“The organization called for immediate action, including suspension of mifepristone’s approval as an abortifacient, prohibition of mail-order, telehealth, and retail pharmacy distribution, limits to in-person medical evaluation and follow-up, reinstatement of comprehensive adverse-event reporting, and release of underlying scientific evidence for prior access expansions.

The report references calls to 27 Planned Parenthood locations in states including Alaska, Colorado, Kansas, Oregon, Minnesota, New Mexico, and New York, where providers allegedly confirmed no ultrasound, Rh testing, medical history review, or follow-up was needed, with flexibility up to 12 weeks gestation and options to delay or redirect shipments.

The post Investigation Shows Planned Parenthood Putting Women at Risk With Dangerous Abortion Pills appeared first on LifeNews.com.